Literature DB >> 30805290

Validation of Pre-operative Templating for Total Disc Replacement Surgery.

Justin F M Hollenbeck1, Jill A Fattor2, Vikas Patel2, Evalina Burger2, Paul J Rullkoetter1, Christopher M J Cain2.   

Abstract

OBJECTIVES: This was an analytic retrospective observational study. The aims were (1) to validate patient-specific templating process by comparing postoperative range of motion (ROM) with that predicted by the model, (2) to retrospectively determine the ideal implant size, height, configuration, and location to evaluate if the ROM achieved could have been improved, and (3) to correlate postoperative ROM and clinical outcome.
BACKGROUND: Previous research revealed that after total disc replacement surgery, 34% of patients with less than 5° of postoperative ROM developed adjacent segment disease. The match between patient anatomy (size, facet orientation, disc height) and implant parameters are likely to affect postoperative ROM and clinical outcomes.
METHODS: Seventeen consecutive patients were implanted with 22 ProDisc-L devices between 2008 and 2015. Three-dimensional finite element (FE) models of the implanted segment were constructed from preoperative computed tomography scans and virtually implanted with the ProDisc-L implant. ROM was determined with the endpoints of facet impingement in flexion and implant contact in extension. FE templating was used to determine the optimal implant size and location. ROM was then measured directly from flexion and extension radiographs and compared to predicted ROM. Pre and postoperative Oswestry Disability Index (ODI) data were used to correlate ROM with clinical outcomes.
RESULTS: No significant difference was found between the actual and predicted ROM. The computational templating procedure identified an optimal ROM that was significantly greater than actual ROM. The ROM in our cohort could have been improved by an average of 1.2° or 12% had a different implant size or position been used.
CONCLUSIONS: FE analyses accurately predicted ROM in this cohort and can facilitate selection of the optimal implant size and location that we believe will increase the chance of achieving clinical success with the application of this technology.

Entities:  

Keywords:  adjacent segment disease; finite element modeling; low back pain; range of motion; total disc replacement

Year:  2019        PMID: 30805290      PMCID: PMC6383453          DOI: 10.14444/6011

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  20 in total

1.  The instant axis of rotation influences facet forces at L5/S1 during flexion/extension and lateral bending.

Authors:  Marc-Antoine Rousseau; David S Bradford; Tamer M Hadi; Kirk L Pedersen; Jeffery C Lotz
Journal:  Eur Spine J       Date:  2005-09-20       Impact factor: 3.134

2.  Measurement error of lumbar total disc replacement range of motion.

Authors:  Moe R Lim; Randall T Loder; Russel C Huang; Stephen Lyman; Kai Zhang; Andrew Sama; Elias C Papadopoulos; Kristin Warner; Federico P Girardi; Frank P Cammisa
Journal:  Spine (Phila Pa 1976)       Date:  2006-05-01       Impact factor: 3.468

Review 3.  Verification, validation and sensitivity studies in computational biomechanics.

Authors:  Andrew E Anderson; Benjamin J Ellis; Jeffrey A Weiss
Journal:  Comput Methods Biomech Biomed Engin       Date:  2007-06       Impact factor: 1.763

4.  Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.

Authors:  Richard D Guyer; Paul C McAfee; Robert J Banco; Fabian D Bitan; Andrew Cappuccino; Fred H Geisler; Stephen H Hochschuler; Richard T Holt; Louis G Jenis; Mohamed E Majd; John J Regan; Scott G Tromanhauser; Douglas C Wong; Scott L Blumenthal
Journal:  Spine J       Date:  2008-09-19       Impact factor: 4.166

5.  Incidence and prevalence of surgery at segments adjacent to a previous posterior lumbar arthrodesis.

Authors:  William R Sears; Ioannis G Sergides; Noojan Kazemi; Mari Smith; Gavin J White; Barbara Osburg
Journal:  Spine J       Date:  2011-01       Impact factor: 4.166

6.  A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.

Authors:  Scott Blumenthal; Paul C McAfee; Richard D Guyer; Stephen H Hochschuler; Fred H Geisler; Richard T Holt; Rolando Garcia; John J Regan; Donna D Ohnmeiss
Journal:  Spine (Phila Pa 1976)       Date:  2005-07-15       Impact factor: 3.468

7.  Range of motion and adjacent level degeneration after lumbar total disc replacement.

Authors:  Russel C Huang; Patrick Tropiano; Thierry Marnay; Federico P Girardi; Moe R Lim; Frank P Cammisa
Journal:  Spine J       Date:  2006 May-Jun       Impact factor: 4.166

8.  Effect of an artificial disc on lumbar spine biomechanics: a probabilistic finite element study.

Authors:  Antonius Rohlmann; Anke Mann; Thomas Zander; Georg Bergmann
Journal:  Eur Spine J       Date:  2008-11-29       Impact factor: 3.134

Review 9.  Lumbar adjacent segment degeneration and disease after arthrodesis and total disc arthroplasty.

Authors:  James S Harrop; Jim A Youssef; Mitch Maltenfort; Peggy Vorwald; Pascal Jabbour; Christopher M Bono; Neil Goldfarb; Alexander R Vaccaro; Alan S Hilibrand
Journal:  Spine (Phila Pa 1976)       Date:  2008-07-01       Impact factor: 3.468

10.  Patient selection for lumbar arthroplasty and arthrodesis: the effect of revision surgery in a controlled, multicenter, randomized study.

Authors:  Fred H Geisler; Richard D Guyer; Scott L Blumenthal; Paul C McAfee; Andrew Cappuccino; Fabien Bitan; John J Regan
Journal:  J Neurosurg Spine       Date:  2008-01
View more
  1 in total

Review 1.  Regulating the fate of stem cells for regenerating the intervertebral disc degeneration.

Authors:  Sobia Ekram; Shumaila Khalid; Asmat Salim; Irfan Khan
Journal:  World J Stem Cells       Date:  2021-12-26       Impact factor: 5.326

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.